Misonix (Nasdaq: MSON) 32.25% HIGHER; Announced the results from its first human kidney cancer treatments using the Sonatherm 600, a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE